Partnership Opportunities
Are you Looking to Position Yourself as a Leader in the Rare Renal Drug Development Field?
The 5th Rare & Genetic Kidney Disease Drug Development Summit returns to Boston from September 29 – October 1, 2025, bringing together 80+ drug developers from established pharma and emerging biotechs. For its fifth year, this exclusive event is designed to tackle the industry's toughest challenges and bottlenecks head-on.
Through extensive conversations with the rare and genetic kidney disease drug development community, we’ve identified their core pain points, including:
- Successful preclinical kidney modelling
- Leveraging automation, AI, and electronic health records for enhanced patient recruitment and retention
- Optimizing genetic testing databases
- Effectively incorporating patient outcomes into clinical trial design as preclinical and clinical pipelines advance toward approval
Partner with us in 2025 to elevate your brand and capitalize on direct access to our audience of leading companies with active pipelines in rare and genetic kidney diseases.
Contract Clinical Research – Accelerate clinical R&D and establish your leadership as the premier clinical CRO in orphan kidney diseases by showcasing unique patient engagement strategies.
Genetic Testing – Highlight your expertise in advanced molecular diagnostics to identify precise patient subgroups, empowering nephrologists with data for more personalized healthcare decisions.
Novel Biomarkers – Communicate your capabilities in validating and accurately quantifying biomarkers for both drug efficacy and disease progression.
Preclinical Services – Elevate your expertise in preclinical models, tissue bioengineering capabilities, and specialized study tools across IgAN, FSGS, Alport Syndrome, PKD, and other rare renal therapeutic areas.
Why Partner in 2025?
Showcase your brand your brand to boost awareness in the rare and genetic space and increase your market share through onsite and preconference marketing strategies
Connect with the key decision-makers to gain their trust in your services by presenting your innovative services in the main agenda to help them achieve clinical success
Generate new business leads with the competitive intelligence on renal drug development available at this niche and focussed meeting to help you reach your 2025 commercial goals
Understand the challenges of the experts in the field to help tailor your solutions to the needs of the industry
Contribute to the rapidly advancing field to bring the next generation of rare, renal disease therapeutics to patients in need faster
Who Will You Meet?
*Statistics taken from the 3rd Rare & Genetic Kidney Disease Drug Development Summit
